Second pivotal phase-3 trial in cystic fibrosis begins
Monday, September 08, 2008 12:00 IST Sydney, Australia
Pharmaceutical company Pharmaxis announced that it has enrolled the first subject into its second pivotal phase-3 clinical trial evaluating Bronchitol in cystic fibrosis sufferers.